Sandimmune (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Sandimmune drug offered from Novartis Pharmaceuticals Corporation. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | cyclosporine |
| SUBSTANCE NAME: | CYCLOSPORINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1983-11-14 |
| END MARKETING DATE: | 0000-00-00 |
Sandimmune HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sandimmune from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 1983-11-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0109_aaeaef94-f3f5-4367-8ea2-b181d7be2da8 |
| PRODUCT NDC: | 0078-0109 |
| APPLICATION NUMBER: | NDA050573 |
Other CYCLOSPORINE Pharmaceutical Manufacturers / Labelers:
